echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > IBD: Taking aspirin daily does not affect the clinical outcome sexist patients with inflammatory bowel disease

    IBD: Taking aspirin daily does not affect the clinical outcome sexist patients with inflammatory bowel disease

    • Last Update: 2020-06-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    BACKGROUND: Although several studies have linked the use of nonsteroidal anti-inflammatory drugs to the onset of disease in patients with inflammatory bowel disease (IBD), little is known about the effects of daily aspirin use on clinical outcomes in patients with IBDThe study looked at the effects of daily aspirin use on the clinical outcomes of patients with inflammatory bowel disease
    methods: The researchers reviewed the data collected on the registration of patients with IBD from May 2008 to June 2015Patients who used aspirin daily were matched 1:4 by age, sex, disease, disease location and whether aspirin was presentThe final analysis included patients who had followed for at least 18 monthsThe main observations were IBD-related hospitalizations during follow-up, IBD-related surgery, and the need for corticosteroid therapyResults: This study included a total of 764 cases of IBD patients, of which 174 were taking aspirinThere was no statistical difference between the two groups in terms of age, sex, diagnosis (Crohn's disease and ulcerative colitis), duration of disease, Charson comorbidity index, smoking status, drug use or baseline C-reactive proteinAfter controlling covariates and follow-up times across the population, the use of aspirin was not related to the risk of hospitalization for IBD-related complications (odds of 1.46;conclusion: The use of aspirin does not affect the primary clinical outcomes of PATIENTs with IBDAlthough the effects of aspirin on mucous membrane inflammation were not directly assessed in this study, these findings support the safety of daily aspirin use in this population
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.